Pirasteh, Ali http://orcid.org/0000-0003-0797-4636
Sorra, E. Aleks http://orcid.org/0000-0003-1970-0755
Marquez, Hector
Sibley, Robert C. http://orcid.org/0000-0001-5075-5071
Fielding, Julia R.
Vij, Abhinav http://orcid.org/0000-0002-1037-2217
Rich, Nicole E. http://orcid.org/0000-0003-2740-8818
Arroyo, Ana
Yopp, Adam C. http://orcid.org/0000-0002-5887-5315
Khatri, Gaurav http://orcid.org/0000-0002-3485-1650
Singal, Amit G.
Yokoo, Takeshi http://orcid.org/0000-0002-5092-6931
Funding for this research was provided by:
National Institutes of Health (U01 C230694)
Article History
Received: 30 November 2020
Revised: 17 February 2021
Accepted: 5 March 2021
First Online: 23 March 2021
Declarations
:
: Ali Pirasteh: GE Healthcare, institutional research support agreement (University of Wisconsin-Madison). Dr. Pirasteh has served as consultant on advisory board for Sanofi Genzyme. E. Aleks Sorra, Hector Marquez, Carson R. Sibley, Julia R. Fielding, Abhinav Vij, Nicole E. Rich, Ana Arroyo, Adam C. Yopp, Gaurav Khatri, Takeshi Yokoo: No disclosures. Amit G. Singal: Dr. Singal has served as consultant or on advisory boards for Bayer, Eisai, Genentech, BMS, Exelixis, AstraZeneca, Wako Diagnostics, Exact Sciences, Roche, Glycotest, GRAIL, and TARGET Pharmasolutions. Dr. Singal also serves on the LI-RADS Steering Committee.